Iskra Pusic, MD, MSCI
Associate Professor
- Phone: 314-454-8304
- Fax: 314-454-7551
- Email: iskrapusic@nospam.wustl.edu
Address:
Division of Oncology
Mail Stop 8007-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110
11th Floor Mid Campus Center (office)
Admin:
Tanya Cuso
tcuso@wustl.edu
- Hematologic malignancies
- Hematopoietic stem cell transplantation
- Chronic graft-versus-host disease
- Chronic graft-versus-host disease
- Graft-versus-tumor effects
- Transplant biology
- Development of new strategies for prevention and treatment of acute and chronic GvHD
- Leading the Tissue Repository for the Analysis of Genetic, Immune, and Clinical Parameters in Hematopoietic Stem Cell Transplantation
- Improving stem cell mobilization strategies
- Clinical trials in stem cell transplantation
- Maintenance therapy after allogeneic stem cell transplantation for AML sand MDS
- Ancillary therapies to enhance post-transplant survivorship
Biosketch
Education
- 1998-1997: Obligatory Medical Traineeship, University Hospital Center “Rebro”, Zagreb, Croatia
- 1997-1991: MD, University of Zagreb School of Medicine, Zagreb, Croatia
Post-Graduate Training
- 2015-2012: Master of Science in Clinical Investigation, Washington University School of Medicine, St. Louis, MO
- 2008-2007: Fellow in Bone Marrow Transplantation and Leukemia, Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO
- 2007-2004: Fellow in Hematology and Oncology, Division of Hematology and Oncology, State University of New York – Downstate, Brooklyn, NY
- 2004-2001: Resident in Internal Medicine, Department of Internal Medicine, State University of New York – Downstate, Brooklyn, NY
- 2001: Post-doctoral Fellow/Research Associate, Division of Oncology, University of Nebraska Medical Center, Lied Transplant Center, Omaha, NE
Academic Positions
- present-2020: Associate Professor, Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
- 2019-2013: Assistant Professor, Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
- 2013-2011: Instructor in Medicine, Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
- 2011-2008: Hospitalist, Department of Medicine, Division of Hospital Medicine, Barnes-Jewish Hospital, St. Louis, MO
University & Hospital Appointments & Committees
- present-2021: Washington University School of Medicine Data and Safety Monitoring Board (DSMB)
- present-2021: Washington University School of Medicine, Goal Deployment Process Team for central line-associated bloodstream infections (CLABSI) reduction
- present-2014: Protocol Review and Monitoring Committee (PRMC)
Board Certification
- 2021, 2009: Hematology, American Board of Internal Medicine
- 2021: Cardio-Oncology, International Cardio-Oncology Society
- 2008: Medical Oncology, American Board of Internal Medicine
- 2004: Internal Medicine, American Board of Internal Medicine
Honors & Awards
- 2022: American Society of Transplantation and Cellular Therapies (ASTCT) 2022 Leadership Course – Tandem Award
- 2020-2018: American Cancer Society-Institutional Research Grant, St. Louis, MO
- 2020-2018: Clinical and Translational Research Funding Program Grant, Washington University Institute of Clinical and Translational Sciences, St. Louis, MO
- 2015-2012: Institute of Clinical and Translational Sciences KL2 Career Development Award, Washington University School of Medicine, St. Louis, MO
- 2009: American Society of Blood and Marrow Transplantation Clinical Research Training Course
- 2008: American Society of Blood and Marrow Transplantation Travel Grant
- 2007: Chronic Graft-versus-Host Disease (GvHD) Workshop – Implementation of the National Institutes of Health (NIH) Consensus Criteria for Clinical Trials, NIH, Bethesda, MD
Editorial Responsibilities
- 2021: International Cardio-Oncology Society, Board Exam Development Committee Member
- 2021: Abstract Reviewer for American Society of Transplantation and Cellular Therapies (ASTCT) meeting, formerly ASBMT
- 2021: Faculty on International Cardio-Oncology Society board review course
- 2020: Coordinating Abstract Reviewer, ASH meeting
- 2019: Abstract Reviewer, American Society of Hematology (ASH) Meeting
National Scientific Panels
- Present-2023: ASTCT- National Marrow Donor Program “ACCESS initiative”, Committee on Poverty
- Present-2022: Center for International Blood and Marrow Transplant Research (CIBMTR) Data Safety Monitoring Board (DSMB)
- present-2020: International Cardio-Oncology Society, Scientific & Research Committee
- present-2020: NIH Chronic GvHD Consensus Working Group, Section on GvHD Etiology and Prevention
- present-2020: State of Science Symposium, GvHD Committee, BMT Clinical Trials Network (CTN)
- present-2019: Committee on Practice Guidelines at American Society of Transplantation and Cellular Therapies (ASTCT)
- present-2019: National Comprehensive Cancer Network (NCCN), Disease-specific Guidelines Panel – Chronic Myeloid Leukemia
Professional Societies & Organizations
- present-2020: International Cardio-Oncology Society
- present-2019: Survivorship Special Interest Group at ASTCT
- present-2018: Women Committee in American Society of Transplantation and Cellular Therapies
- present-2015: Clinical Trials Network
- 2018-2016: Association of Croatian American Professionals, Medicine and Health Sciences Section
- present-2004: American Society of Hematology
- present-2004: American Society of Transplantation and Cellular Therapies (ASTCT); previously ASBMT
- present-2008: Center for International Blood and Marrow Transplant Research, GvHD Working Committee
- present-2009: Rare Diseases Clinical Research Network – Chronic GVHD Consortium